BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36661917)

  • 21. Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement.
    Sinning JM; Wollert KC; Sedaghat A; Widera C; Radermacher MC; Descoups C; Hammerstingl C; Weber M; Stundl A; Ghanem A; Widder J; Vasa-Nicotera M; Mellert F; Schiller W; Bauersachs J; Zur B; Holdenrieder S; Welz A; Grube E; Pencina MJ; Nickenig G; Werner N; Kempf T
    Am Heart J; 2015 Oct; 170(4):821-9. PubMed ID: 26386807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New Cardiovascular Biomarkers in Ischemic Heart Disease-GDF-15, A Probable Predictor for Ejection Fraction.
    Dalos D; Spinka G; Schneider M; Wernly B; Paar V; Hoppe U; Litschauer B; Strametz-Juranek J; Sponder M
    J Clin Med; 2019 Jun; 8(7):. PubMed ID: 31252588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-biomarker analysis in patients after transcatheter aortic valve implantation (TAVI).
    Mirna M; Wernly B; Paar V; Jung C; Jirak P; Figulla HR; Kretzschmar D; Franz M; Hoppe UC; Lichtenauer M; Lauten A
    Biomarkers; 2018 Dec; 23(8):773-780. PubMed ID: 30041555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between B-type natriuretic peptide and invasive haemodynamics in patients with severe aortic valve stenosis.
    Maeder MT; Weber L; Ammann P; Buser M; Ehl NF; Gerhard M; Brenner R; Haager PK; Maisano F; Rickli H
    ESC Heart Fail; 2020 Apr; 7(2):577-587. PubMed ID: 31994357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary Hypertension in Patients With Severe Aortic Stenosis: Prognostic Impact After Transcatheter Aortic Valve Replacement: Pulmonary Hypertension in Patients Undergoing TAVR.
    Alushi B; Beckhoff F; Leistner D; Franz M; Reinthaler M; Stähli BE; Morguet A; Figulla HR; Doenst T; Maisano F; Falk V; Landmesser U; Lauten A
    JACC Cardiovasc Imaging; 2019 Apr; 12(4):591-601. PubMed ID: 29680341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GDF-15 (Growth Differentiation Factor 15) Is Associated With Lack of Ventricular Recovery and Mortality After Transcatheter Aortic Valve Replacement.
    Kim JB; Kobayashi Y; Moneghetti KJ; Brenner DA; O'Malley R; Schnittger I; Wu JC; Murtagh G; Beshiri A; Fischbein M; Miller DC; Liang D; Yeung AC; Haddad F; Fearon WF
    Circ Cardiovasc Interv; 2017 Dec; 10(12):. PubMed ID: 29222133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre- and Post-Transcatheter Aortic Valve Replacement Serum Brain Natriuretic Peptide Levels and All-Cause Mortality.
    Elbaz-Greener G; Ghanim D; Kusniec F; Rabin A; Sudarsky D; Carasso S; Czeiger T; Shoan-Dayan M; Sakhnini A; Grosman-Rimon L; Strauss BH; Wijeysundra HC; Amir O
    Cardiology; 2020; 145(12):813-821. PubMed ID: 33070124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic role of pulmonary hemodynamics before transcatheter aortic valve replacement among patients with severe aortic stenosis.
    Dahiya G; Kyvernitakis A; Elhamdani A; Begg A; Doyle M; Elsayed M; Bailey S; Raina A; Kanwar M; Biederman RWW; Benza RL
    J Heart Lung Transplant; 2023 Feb; 42(2):275-282. PubMed ID: 36437170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: study from the FRANCE 2 Registry.
    Luçon A; Oger E; Bedossa M; Boulmier D; Verhoye JP; Eltchaninoff H; Iung B; Leguerrier A; Laskar M; Leprince P; Gilard M; Le Breton H
    Circ Cardiovasc Interv; 2014 Apr; 7(2):240-7. PubMed ID: 24569597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin for Risk Stratification in Low-Flow, Low-Gradient Aortic Stenosis: A Substudy of the TOPAS Study.
    Dahou A; Clavel MA; Capoulade R; O'Connor K; Ribeiro HB; Côté N; Le Ven F; Rodés-Cabau J; Dumesnil JG; Mathieu P; Pibarot P
    JACC Cardiovasc Imaging; 2018 Jul; 11(7):939-947. PubMed ID: 28917673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aortic Stenosis Prognostication in Patients With Type 2 Diabetes: Protocol for Testing and Validation of a Biomarker-Derived Scoring System.
    Giritharan S; Cagampang F; Torrens C; Salhiyyah K; Duggan S; Ohri S
    JMIR Res Protoc; 2019 Aug; 8(8):e13186. PubMed ID: 31407670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening For Pulmonary Hypertension With Multidetector Computed Tomography Among Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation.
    O'Sullivan CJ; Montalbetti M; Zbinden R; Kurz DJ; Bernheim AM; Liew A; Meyer MR; Tüller D; Eberli FR
    Front Cardiovasc Med; 2018; 5():63. PubMed ID: 29951486
    [No Abstract]   [Full Text] [Related]  

  • 33. Novel Biomarkers in Patients with Chronic Kidney Disease: An Analysis of Patients Enrolled in the GCKD-Study.
    Mirna M; Topf A; Wernly B; Rezar R; Paar V; Jung C; Salmhofer H; Kopp K; Hoppe UC; Schulze PC; Kretzschmar D; Schneider MP; Schultheiss UT; Sommerer C; Paul K; Wolf G; Lichtenauer M; Busch M
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32213894
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of Periprocedural Pulmonary Hypertension on Outcomes After Transcatheter Aortic Valve Replacement.
    Miyamoto J; Ohno Y; Kamioka N; Ikari Y; Otsuka T; Tada N; Naganuma T; Yamawaki M; Yamanaka F; Shirai S; Mizutani K; Tabata M; Ueno H; Takagi K; Watanabe Y; Yamamoto M; Hayashida K;
    J Am Coll Cardiol; 2022 Oct; 80(17):1601-1613. PubMed ID: 36265955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary hypertension due to left heart disease: diagnostic value of pulmonary artery distensibility.
    Colin GC; Verlynde G; Pouleur AC; Gerber BL; Beauloye C; Kefer J; Coche E; Vachiéry JL; Gevenois PA; Ghaye B
    Eur Radiol; 2020 Nov; 30(11):6204-6212. PubMed ID: 32548647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multibiomarker analysis in patients with acute myocardial infarction.
    Schernthaner C; Lichtenauer M; Wernly B; Paar V; Pistulli R; Rohm I; Jung C; Figulla HR; Yilmaz A; Cadamuro J; Haschke-Becher E; Pernow J; Schulze PC; Hoppe UC; Kretzschmar D
    Eur J Clin Invest; 2017 Sep; 47(9):638-648. PubMed ID: 28683166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-type natriuretic peptide is associated with remodeling and exercise capacity after transcatheter aortic valve replacement for aortic stenosis.
    Sato K; Kumar A; Krishnaswamy A; Mick S; Desai MY; Griffin BP; Kapadia SR; Popović ZB
    Clin Cardiol; 2019 Feb; 42(2):270-276. PubMed ID: 30565264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of CT signs and measurements as a predictor of pulmonary hypertension and mortality in symptomatic severe aortic valve stenosis.
    Eberhard M; Mastalerz M; Pavicevic J; Frauenfelder T; Nietlispach F; Maisano F; Tanner FC; Nguyen-Kim TDL
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1637-1651. PubMed ID: 28550588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Transcatheter Aortic Valve Replacement on Right Ventricular-Pulmonary Artery Coupling.
    Eleid MF; Padang R; Pislaru SV; Greason KL; Crestanello J; Nkomo VT; Pellikka PA; Jentzer JC; Gulati R; Sandhu GS; Holmes DR; Nishimura RA; Rihal CS; Borlaug BA
    JACC Cardiovasc Interv; 2019 Nov; 12(21):2145-2154. PubMed ID: 31699376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of aortic stenosis according to invasive cardiac damage staging after transcatheter aortic valve replacement.
    Schewel J; Kuck KH; Frerker C; Schmidt T; Schewel D
    Clin Res Cardiol; 2021 May; 110(5):699-710. PubMed ID: 33744987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.